I support H.R. 3163, and I am glad that we have been able to work on a bipartisan basis on this important bill to ensure continued patient access to these important drugs at home.

It is long past overdue for us to have a serious discussion about a permanent policy to address these caps.

Thank you, Mr. Chairman. And thanks for holding the hearing to provide us with a market participant perspective in our system of electricity regulation.

the 340B program is not the problem or the solution to rising drug prices

the 340B program does play a valuable role in our efforts to provide a robust safety net for vulnerable patients

The 340B program is a critical component of the safety net that serves the most vulnerable among us and 340B drug discounts help safety net providers make the most of the limited resources they receive.

It is critical that our committee, at a minimum, take the time we need to examine these matters so that we arrive at decisions that are informed by fact and that serve the interests of our districts, our states, and the nation as a whole.

this rule would have zero impact on the actual price of prescription drugs

As a result, they are able to reach more eligible patients and provide those patients with more comprehensive health services, and I believe in both protecting 340B and improving the integrity of the program to ensure it remains strong for…

Twenty-five years ago, Congress passed bipartisan legislation establishing the 340B program. Since its inception, the 340B program has played a critical role in ensuring that low-income and vulnerable individuals have access to affordable…

I hope that our discussion today will help to inform whether or not it would be appropriate for this committee to take further action.

To the contrary, though, I think Medicaid has provided for a great deal of innovation in how states have responded to the opioid crisis.